From Biopsy to Bedside in a Week: Inside the GUSTO Trial 

GUSTO trial focuses on muscle-invasive bladder cancer treatment.

Aims to tailor therapy based on genetic subtypes.

Achieves rapid gene expression results in under 7 days.

Team includes multiple healthcare professionals and partners.

Received recognition from the Royal College of Pathologists.

Potential to inform design of phase 3 trials.

Demonstrates importance of academic-clinical partnerships in diagnostics.